breast cancer - HR positive | |
la/mBC - HR-positive - 2nd line (L2) | |
Immunostimulant | |
vaccine | |
OBI-822/OBI-821 plus cyclophosphamide | Huang |
Study type:
delta: difference in rate or median (if available)
- About us - Contact us - Method - RSS Made with in Lyon - Credits - Privacy policy -